<DOC>
	<DOC>NCT00806468</DOC>
	<brief_summary>This study will be conducted to study the effect of Desmopressin on the nocturnal micturition frequency in patients with idiopathic Parkinson syndrome.</brief_summary>
	<brief_title>Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<criteria>Male patients with idiopathic Parkinson Syndrome 18 to 85 years Nocturnal Pollakisuria &gt; 2 mictions /night (documented in Screening phase ) Na+ i.S &gt; 135 mmol/l Patient is able to understand all aspects and individual consequences of the clinical trial An informed consent signed and dated by the patient is available prior to any study specific treatment The study is consistent with the patientsÂ´ request for an appropriate treatment Intake of the following concomitant medication: Carbamazepin, Oxcarbazepine, diuretics (Furosemide, Torasemide), non steroidal antiphlogistics, Loperamide, antidiuretic hormone analoga (besides study medication), drugs for treatment of bladder disfunction, in particular anticholinergics Central Diabetes insipidus Known heart insufficiency (NYHA Stad. III und IV) clinical relevant kidney insufficiency Habitual and psychogenic Polydipsia Hypersensitivity or allergy against the trial medication or any other ingredient of the trial medication Participation in another clinical trial during or within 6 months prior to this clinical trial Medical or psychological condition, which might endanger the proper conduction of the clinical trial Known drug or alcohol abuse</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>nycturia</keyword>
	<keyword>Parkinson syndrome</keyword>
	<keyword>desmopressin</keyword>
	<keyword>Nocturnal polyuria in patients with Parkinson syndrome</keyword>
</DOC>